SHA-68

SHA-68
(IUPAC) ime
	N-[(4-fluorofenil)metil]-3-okso-1,1-difenil-5,6,8,8a-tetrahidro-[1,3]oksazolo[3,4-a]pirazin-7-karboksamid
Klinički podaci
Identifikatori
ATC kod	nije dodeljen
PubChem	11374217
Hemijski podaci
Formula	C26H24FN3O3
Mol. masa	445.484 g/mol
SMILES	eMolekuli & PubHem
InChI
	InChI=1S/C26H24FN3O3/c27-22-13-11-19(12-14-22)17-28-24(31)29-15-16-30-23(18-29)26(33-25(30)32,20-7-3-1-4-8-20)21-9-5-2-6-10-21/h1-14,23H,15-18H2,(H,28,31) ; Key: SFRQIPRTNYHJHP-UHFFFAOYSA-N
Farmakoinformacioni podaci
Trudnoća	?
Pravni status

SHA-68 je lek koji deluje kao selektivni, ne-peptidni antagonist neuropeptidnog S receptora NPSR. U životinjskim studijama on izaziva uznemirenost, i blokira stimulišuće dejstvo neuropeptida S.^[3]^[4]

Reference[uredi | uredi kod]

↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
↑ Fukatsu K, Nakayama Y, Tarui N, Mori M, Matsumoto H, Kurasawa O, Banno H. Bicyclic Piperazine Compound and Use Thereof. PCT Patent WO 2005/021555 A1. Published 26.08.2004
↑ Okamura N, Habay SA, Zeng J, Chamberlin AR, Reinscheid RK (June 2008). „Synthesis and pharmacological in vitro and in vivo profile of 3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-apyrazine-7-carboxylic acid 4-fluoro-benzylamide (SHA 68), a selective antagonist of the neuropeptide S receptor”]. The Journal of Pharmacology and Experimental Therapeutics 325 (3): 893–901. DOI:10.1124/jpet.107.135103. PMC 2583099. PMID 18337476.

	Portal Medicina
	Portal Hemija

Molimo Vas, obratite pažnju na važno upozorenje u vezi tema o zdravlju (medicini).